ArticlePLoS medicine2011
Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents.
Article in PLoS medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
77 citing papers in PubMed, 5 syntheses or guidelines pooled it, 153 citations in OpenAlex.
- Content Analysis of the Corporate Social Responsibility Practices of 9 Major Cannabis Companies in Canada and the US.JAMA network open · 2022Pooled it
- Alcohol industry corporate social responsibility initiatives and harmful drinking: a systematic review.European journal of public health · 2018Pooled it
- How does the alcohol industry attempt to influence marketing regulations? A systematic review.Addiction (Abingdon, England) · 2016Pooled it
- The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.Cancer causes & control : CCC · 2012Pooled it
- Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control.PLoS medicine · 2012Pooled it
- Purdue's development of abuse-deterrent formulation opioids as a response to market competition: An industry documents analysis.SSM. Qualitative research in health · 2026Article
- Tobacco use in the context of natural disasters: a scoping review pertinent to tobacco control in Indonesia.BMJ open · 2026Article
- Improving legislation is a necessity: A multi-method quantitative analysis of tobacco sponsorship and publicity in China.Tobacco induced diseases · 2026Article
- Article
- Marketing behind charity: Media narratives of tobacco industry donations in China.Tobacco induced diseases · 2025Article
- Navigating Challenges in Tobacco Control: A Systematic Review of Barriers to Implementing Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC).Addiction & health · 2025Review
- Conflicts of interest and the role of governments in tobacco control.Tobacco induced diseases · 2025Article
- Tobacco industry corporate social responsibility activities and other interference after ratification of a strong tobacco law in Ethiopia.Tobacco control · 2024Article
- New image, same tactics: global tobacco and vaping industry strategies to promote youth vaping.Health promotion international · 2024Article
- Lobbying in the Sunlight: A Scoping Review of Frameworks to Measure the Accessibility of Lobbying Disclosures.International journal of health policy and management · 2024Article
- Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy.International journal of health policy and management · 2024Article
- Lobbying by omission: what is known and unknown about harmful industry lobbyists in Australia.Health promotion international · 2023Article
- Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research.The Lancet. Respiratory medicine · 2022Review
- "Using information to shape perception": tobacco industry documents study of the evolution of Corporate Affairs in the Miller Brewing Company.Globalization and health · 2022Article
- "Part of the Solution": Food Corporation Strategies for Regulatory Capture and Legitimacy.International journal of health policy and management · 2021Review
17 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundRecent attempts by large tobacco companies to represent themselves as socially responsible have been widely dismissed as image management. Existing research supports such claims by pointing to the failings and misleading nature of corporate social responsibility (CSR) initiatives. However, few studies have focused in depth on what tobacco companies hoped to achieve through CSR or reflected on the extent to which these ambitions have been realised. METHODS AND
findingsIterative searching relating to CSR strategies was undertaken of internal British American Tobacco (BAT) documents, released through litigation in the US. Relevant documents (764) were indexed and qualitatively analysed. In the past decade, BAT has actively developed a wide-ranging CSR programme. Company documents indicate that one of the key aims of this programme was to help the company secure access to policymakers and, thereby, increase the company's chances of influencing policy decisions. Taking the UK as a case study, this paper demonstrates the way in which CSR can be used to renew and maintain dialogue with policymakers, even in ostensibly unreceptive political contexts. In practice, the impact of this political use of CSR is likely to be context specific; depending on factors such as policy élites' understanding of the credibility of companies as a reliable source of information.
conclusionsThe findings suggest that tobacco company CSR strategies can enable access to and dialogue with policymakers and provide opportunities for issue definition. CSR should therefore be seen as a form of corporate political activity. This underlines the need for broad implementation of Article 5.3 of the Framework Convention on Tobacco Control. Measures are needed to ensure transparency of interactions between all parts of government and the tobacco industry and for policy makers to be made more aware of what companies hope to achieve through CSR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.